Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de VIVA Biotech Holdings?

Accepted Answer

Según el último estado financiero (Form-10K), VIVA Biotech Holdings tiene un total de activos de $7,050, una ganancia neta profit de $167

Question 2

¿Cuáles son los ratios financieros clave para VBIZF?

Accepted Answer

El ratio corriente de VIVA Biotech Holdings es 2.17, el margen neto es 8.4, las ventas por acción son $0.69.

Question 3

¿Cómo se desglosan los ingresos de VIVA Biotech Holdings por segmento o geografía?

Accepted Answer

VIVA Biotech Holdings largest revenue segment is Contract Development Manufacture Organisation and Commercialisation, at a revenue of 1,274,746,963 in the most earnings release.For geography, United States is the primary market for VIVA Biotech Holdings, at a revenue of 862,858,981.

Question 4

¿Es rentable VIVA Biotech Holdings?

Accepted Answer

yes, según los últimos estados financieros, VIVA Biotech Holdings tiene una ganancia neta profit de $167

Question 5

¿Tiene VIVA Biotech Holdings alguna deuda?

Accepted Answer

yes, VIVA Biotech Holdings tiene una deuda de 3,248

Question 6

¿Cuántas acciones en circulación tiene VIVA Biotech Holdings?

Accepted Answer

VIVA Biotech Holdings tiene un total de acciones en circulación de 2,113.16

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,836	1,986	2,155	2,379	2,104	696
Revenue Growth (YoY)	-8%	-8%	-9%	13%	202%	114.99%
Cost of Revenue	1,149	1,299	1,417	1,563	1,453	392
Gross Profit	687	687	738	815	650	304
Selling, General & Admin	373	364	409	404	320	123
Research & Development	85	87	127	135	92	66
Operating Expenses	471	458	503	520	390	215
Other Non Operating Income (Expenses)	--	0	174	10	137	-547
Pretax Income	281	295	-55	-459	347	-356
Income Tax Expense	55	73	43	45	47	22
Net Income	172	167	-116	-528	287	-386
Net Income Growth	--	-244%	-78%	-284%	-174%	-246%
Shares Outstanding (Diluted)	2,509.02	2,868.36	1,940.47	1,915.43	1,970.79	1,571.5
Shares Change (YoY)	17%	48%	1%	-3%	25%	6%
EPS (Diluted)	0.06	0.05	-0.05	-0.27	0.14	-0.24
EPS Growth	-1,352%	-197%	-78%	-297%	-157%	-238%
Free Cash Flow	213	182	195	136	-487	-560
Free Cash Flow Per Share	0.08	0.06	0.1	0.07	-0.24	-0.35
Gross Margin	37.41%	34.59%	34.24%	34.25%	30.89%	43.67%
Operating Margin	11.71%	11.53%	10.85%	12.4%	12.35%	12.78%
Profit Margin	9.36%	8.4%	-5.38%	-22.19%	13.64%	-55.45%
Free Cash Flow Margin	11.6%	9.16%	9.04%	5.71%	-23.14%	-80.45%
EBITDA	432	442	445	480	413	158
EBITDA Margin	23.52%	22.25%	20.64%	20.17%	19.62%	22.7%
D&A For EBITDA	217	213	211	185	153	69
EBIT	215	229	234	295	260	89
EBIT Margin	11.71%	11.53%	10.85%	12.4%	12.35%	12.78%
Effective Tax Rate	19.57%	24.74%	-78.18%	-9.8%	13.54%	-6.17%

VIVA Biotech Holdings (VBIZF) Price

VBIZF Stock Price Chart

VBIZF Income

Follow-Up Questions